Key result
Transcatheter closure with STARFlex-type devices is associated with significantly decreased residual VSD shunting.
Why the study?
A comprehensive description of outcomes after transcatheter device closure of unrepaired congenital or postoperative residual VSDs over a long-term experience was needed.
Does transcatheter device closure improve clinical status and decrease shunting in patients with congenital and postoperative residual VSDs?
Cohort (n=170)
Does transcatheter device closure improve clinical status and decrease shunting in patients with congenital and postoperative residual VSDs?
Answers are grounded in this paper and cite their sources.
Transcatheter device closure of congenital and postoperative VSDs using STARFlex-type devices is effective for reducing left-to-right shunting and improving VSD size/severity, though periprocedural events are frequent.
Background— Our purpose was to describe a 13-year experience with patients undergoing transcatheter device closure of unrepaired congenital or postoperative residual ventricular septal defects (VSDs). Methods and Results— Since 1989, 170 patients (median age, 3.9 years) have undergone catheterization for closure of 1 or more congenital (n=92) or postoperative (n=78) residual VSDs using successive generations of STARFlex-type devices. Outcomes included echocardiographic assessment of residual flow and device position, assessment of VSD shunt/severity, and adverse events. Among 168 patients in whom device implantation was performed, between 1 and 7 devices were placed per patient (median, 1), with multiple devices placed in 40%. There was a significant decrease in left-to-right shunting after device implantation ( P <0.001) and significant improvement in VSD size/severity, and device position proved stable. Of 332 adverse events, 39 were related to the device and 261 were related to the catheterization; all but 5 occurred in the periprocedural period. At a median follow-up of 24 months (0 to 154 months), 14 patients had died and 18 had device(s) explanted. Conclusions— Congenital and postoperative VSD closure using STARFlex-type devices resulted in stable improvement in clinical status and decreased interventricular shunting. Although periprocedural events occurred frequently, late events caused by the device were rare. Transcatheter device closure is an effective management option for patients with complex muscular VSDs that are difficult to approach surgically and for postoperative residual VSDs.
No takes yet. Share an insight, caveat, or question.
Knauth et al. (2004) conducted a cohort in Unrepaired congenital or postoperative residual ventricular septal defects (VSDs) (n=170). Transcatheter device closure using STARFlex-type devices was evaluated on Left-to-right shunting (p=<0.001). Transcatheter device closure of ventricular septal defects using STARFlex-type devices decreased left-to-right shunting over a median 24-month follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: